Abstract:OBJECTIVE:Glycogen debranching enzyme (AGL) plays an important role in complete degradation of the glycogen, and has two independent catalytic activities, i.e., those of alpha-1, 4-glucanotransferase (EC 2.4. 1.25) and amylo-1,6-glucosidase (EC 3.2. 1.33). A deficiency in activities of AGL causes excessive accumulation of glycogen with short branched outer chains and results in glycogen storage disease type III (GSD III; MIM #232 400), an autosomal recessive inborn disorder of glycogen metabolism. The present study aimed to investigate the mutation of AGL in 10 Chinese patients with GSD III.METHOD:Clinical and laboratory data of 10 patients with typical clinical manifestations of GSD III suggesting hypoglycemia, hyperlipidemia, increased creatine-phosphokinase and its isozyme were collected. The coding regions and their flanking introns of AGL gene of the 10 patients were amplified by PCR and analyzed by direct DNA sequencing. All the mutated alleles were confirmed by bidirectional DNA sequencing. The 3 novel splicing mutations were analyzed by restriction fragment length polymorphism (RFLP) in 50 healthy children (control). The 2 small deletions (c.408-411delTTTG, c.2717-2721delAGATC) were analyzed by fluorescent polymerase chain reaction and gene scan analysis to confirm the number of deleted bases.RESULT:Thirteen different mutations were identified, including 4 splicing mutations (IVS6 + 1G > A, IVS6-1G > A, IVS14 + 1G > T, IVS26-2A > C), 5 nonsense mutations (R469X, R864X, S929X, R977X, Y1428X), 3 small deletions (c.408-411delTTTG, c.2717-2721delAGATC, c.2823delT) and 1 insert mutation (c.4234insT). Except for IVS14 + 1G > T, R864X, and R977X, the other 10 mutations are novel; 18 mutated alleles were identified in the 20 alleles (90%). IVS14 + 1G > T was the most frequently seen mutation, accounting for 5 of 20 (25%) alleles examined. None of homozygote and heterozygote of the 3 novel splicing mutations was found in the 50 healthy controls by RFLP analysis. With the fluorescent polymerase chain reaction and gene scan analysis, c.408411deTTTG mutation and c.2717-2721delAGATC mutation were confirmed to have 4 and 5 bases deletion respectively.CONCLUSION:Thirteen mutations were identified in the 10 cases with GSD III, with 10 novel mutations. IVS14 + 1G > T was a relatively common mutation. This study revealed the heterozygosity of AGL gene in Chinese patients with GSD III.

Prenatal Diagnosis of Glycogen Storage Disease Ia by Screening for Hot Spot Mutations in Combination with the 1176 Nucleotide Polymorphism Linkage Analysis

[Application of enzyme assay and gene analysis in the prenatal diagnosis for a family with glycogen storage disease type II].

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia

Rapid detection of glycogen storage disease type Ia by DNA microarray

Clinical and genomic study of the infant with glycogen storage disease typeⅡ

Gene mutation and clinical study in the patients with glycogen storage disease type Ⅰ a

Glycogen storage disease typeⅠa:a pedigree study

Molecular Genetic Analysis of 10 Chinese Patients with Glycogen Storage Disease Type Iii

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

A Novel Homozygous No-Stop Mutation in G6pc Gene from A Chinese Patient with Glycogen Storage Disease Type Ia

[AGL gene analysis of a pedigree with glycogen storage disease type III and identification of a novel mutation]

Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flowchart

Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases

A Novel Type Heterozygous Mutation in the Glucose-6-phosphatase Gene in a Chinese Patient with Glycogen Storage Disease Ia.

[Clinical Characteristics and Genetic Analysis of a Chinese Pedigree Affected by Glycogen Storage Disease Type Ia with Gout As the First Manifestation].

Genetic Analysis and Clinical Assessment of Four Patients with Glycogen Storage Disease Type IIIa in China

Molecular diagnosis and mutation identification in newborn with glucose-6-phosphate dehydrogenase deficiency by DNA sequencing

Pseudodeficiency alleles affect the newborn screening of glycogen storage disease typeⅡ

Prenatal Diagnosis of Glutaric Acidemia I Based on Amniotic Fluid Samples in 42 Families Using Genetic and Biochemical Approaches

Clinical features and PHKG2 gene mutation analysis of 5 Chinese patients with glycogen storage disease Ⅸc

DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis